1. Home
  2. GHRS vs IAUX Comparison

GHRS vs IAUX Comparison

Compare GHRS & IAUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • IAUX
  • Stock Information
  • Founded
  • GHRS 2018
  • IAUX 2020
  • Country
  • GHRS Ireland
  • IAUX United States
  • Employees
  • GHRS N/A
  • IAUX N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • IAUX
  • Sector
  • GHRS Health Care
  • IAUX
  • Exchange
  • GHRS Nasdaq
  • IAUX Nasdaq
  • Market Cap
  • GHRS 774.1M
  • IAUX 775.8M
  • IPO Year
  • GHRS 2021
  • IAUX N/A
  • Fundamental
  • Price
  • GHRS $13.10
  • IAUX $0.95
  • Analyst Decision
  • GHRS Strong Buy
  • IAUX Buy
  • Analyst Count
  • GHRS 8
  • IAUX 1
  • Target Price
  • GHRS $30.63
  • IAUX $1.50
  • AVG Volume (30 Days)
  • GHRS 307.7K
  • IAUX 7.1M
  • Earning Date
  • GHRS 11-13-2025
  • IAUX 11-11-2025
  • Dividend Yield
  • GHRS N/A
  • IAUX N/A
  • EPS Growth
  • GHRS N/A
  • IAUX N/A
  • EPS
  • GHRS N/A
  • IAUX N/A
  • Revenue
  • GHRS N/A
  • IAUX $76,622,000.00
  • Revenue This Year
  • GHRS N/A
  • IAUX $79.79
  • Revenue Next Year
  • GHRS N/A
  • IAUX $92.04
  • P/E Ratio
  • GHRS N/A
  • IAUX N/A
  • Revenue Growth
  • GHRS N/A
  • IAUX 40.21
  • 52 Week Low
  • GHRS $6.00
  • IAUX $0.34
  • 52 Week High
  • GHRS $20.50
  • IAUX $1.25
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 45.98
  • IAUX 61.43
  • Support Level
  • GHRS $13.00
  • IAUX $0.91
  • Resistance Level
  • GHRS $14.96
  • IAUX $1.00
  • Average True Range (ATR)
  • GHRS 0.78
  • IAUX 0.06
  • MACD
  • GHRS -0.00
  • IAUX -0.01
  • Stochastic Oscillator
  • GHRS 28.46
  • IAUX 46.29

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About IAUX i-80 Gold Corp.

i-80 Gold Corp is a well-financed gold and silver producer engaged in the exploration, development, and production of gold, silver, and poly-metallic deposits. The Company's principal assets include the Ruby Hill Mine, Lone Tree Mine, Granite Creek Mine, and McCoy-Cove Project.

Share on Social Networks: